Research Center for Emergency Medicine, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Acta Anaesthesiol Scand. 2022 Feb;66(2):273-281. doi: 10.1111/aas.14008. Epub 2021 Dec 10.
We investigated hospital-level variation in outcomes after in-hospital cardiac arrest (IHCA) in Denmark, and assessed whether variation in outcomes could be explained by differences in patient characteristics.
Adult patients (≥18 years old) with IHCA in 2017 and 2018 were included from the Danish IHCA Registry (DANARREST). Data on patient characteristics and outcomes were obtained from population-based registries. Predicted probabilities, likelihood ratio tests, intraclass correlation coefficients (ICCs), and median odds ratios (ORs) were calculated for return of spontaneous circulation (ROSC), survival to 30 days, and survival to 1 year.
A total of 3340 patients with IHCA from 24 hospitals were included. We found that hospital-level variation in outcomes after IHCA existed across all measures of variation. The unadjusted median OR for ROSC, survival to 30 days, and survival to 1 year were 1.28 (95% confidence interval [CI]: 1.24, 1.45), 1.38 (95% CI: 1.33, 1.60), and 1.44 (95% CI: 1.39, 1.70), respectively. The unadjusted ICC suggest that 2.0% (95%: 1.6%, 4.4%), 3.3% (95%: 2.7%, 6.8%), and 4.3% (95%: 3.5%, 8.6%) of the total individual variation in ROSC, survival to 30 days, and survival to 1 year was attributable to hospital-level variation. These results decreased but persisted in the analyses adjusted for select patient characteristics.
In this study, we found that outcomes after IHCA varied across hospitals in Denmark. However, only about 2%-4% of the total individual variation in outcomes after IHCA was attributable to differences between hospitals, suggesting that most of the individual variation in outcomes was attributable to patient-level variation.
我们研究了丹麦院内心搏骤停(IHCA)后的医院间结局差异,并评估了结局差异是否可以用患者特征的差异来解释。
纳入了 2017 年和 2018 年丹麦 IHCA 登记处(DANARREST)中年龄≥18 岁的成人 IHCA 患者。患者特征和结局数据来自基于人群的登记处。计算了自主循环恢复(ROSC)、30 天生存和 1 年生存的预测概率、似然比检验、组内相关系数(ICC)和中位数优势比(OR)。
共纳入了来自 24 家医院的 3340 例 IHCA 患者。我们发现,IHCA 后所有结局指标的医院间差异均存在。未调整的 ROSC、30 天生存和 1 年生存的 OR 中位数分别为 1.28(95%CI:1.24,1.45)、1.38(95%CI:1.33,1.60)和 1.44(95%CI:1.39,1.70)。未调整的 ICC 提示,ROSC、30 天生存和 1 年生存的个体差异中,2.0%(95%CI:1.6%,4.4%)、3.3%(95%CI:2.7%,6.8%)和 4.3%(95%CI:3.5%,8.6%)归因于医院间差异。这些结果在调整了部分患者特征后有所减少,但仍存在。
在本研究中,我们发现丹麦不同医院的 IHCA 后结局存在差异。然而,只有约 2%-4%的 IHCA 后结局的个体差异归因于医院间差异,这表明结局的个体差异主要归因于患者水平的差异。